Mark Rackham, VP Chemistry at BenevolentAI will be giving a talk at the “Hatfield MedChem" meeting this spring! More info
Bryn Williams-Jones, Director of Exploratory Research at BenevolentAI will be participating to a panel discussion around AI in Life Sciences at the Elixir Bioinformatics Supplier Forum
Andrea Taddei, Mechanistic Area Lead at BenevolentAI will be presenting at Elrig event on Artificial Intelligence - From Data to Drugs. This presentation will give an overview of the various ways that AI is being applied to find new uses for existing drugs, as well as finding novel treatments for diseases. We will highlight where progress has been fast and where challenges (for example, data availability) still remain, making subtle, well placed reference to how we are doing this along the way.
Nathan Brown, Head of Cheminformatics at BenevolentAI will be participating to a discussion at the Francis Crick Institute around “the challenges preventing Cancer cure”
Join Alix Lacoste VP Data Science and Michelle Gill, Senior Data Scientist at BenevolentAI for a presentation on "Machine Learning for Target Identification and Lead Optimization in Drug Discovery".
Join Ian Chucher, SVP Drug Discovery at BenevolentAI for a talk on Artificial Intelligence - From Data to Drugs at the Royal Society of Medicine. Ian will give an overview of the various ways that AI is being applied to find new uses for existing drugs, as well as finding novel treatments for diseases.
Join Joanna Shields, CEO at BenevolentAI for a speech at the Digital-Life-Design conference in Munich. DLD stands for Digital, Life, Design and explores how the digital age fundamentally changes our lives, society and business.
Join Joanna Shields, CEO at BenevolentAI for a keynote at the JP Morgan Healthcare Conference. The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community
Join Joanna Shields, CEO BenevolentAI, Robert Nelsen, Co-Founder & Managing Director, ARCH Venture Partners and Jennifer Esposito, Worldwide General Manager, Health and Life Sciences Group, Intel Corporation at The Forbes Healthcare Summit for a panel on How Smart Is Artificial Intelligence
Join Mark Davies at Global Engage congress on pharmaceuticals research & development. Mark Davies will present on how Artificial Intelligence (AI) is disrupting drug discovery.
Join Jackie Hunter at the Endpoints London Biotech Summit for a discussion on ROI and Innovation in drug development: What are the big and little biopharmas doing to change the equation?
Join Marwin Segler, Lead Machine Learning Researcher at Elrig event on Drug Discovery for Small & Large Molecules
This September, Marc Davies, VP Biomedical Informatics will be presenting at the Artificial Intelligence in Drug Development Congress on how machine learning technologies are changing how new medicines are discovered and developed.